
Following the unforeseen shooting in Orlando, Democrats demand for reform on gun control laws. After an over 24-hour sit-in on the House floor, Minority Leader Nancy Pelosi (D-Calif.) clutches onto Rep. John Lewis (D-Ga.) as he addresses reporters and protestors, promoting their aggressive campaign towards strict gun laws on June 23, 2016.

After losing his leg in a car accident, Jake Dahreddine, 21, surpasses the physical limitation of having one leg by conquering difficult tasks overlooked by able-bodied human beings. Dahreddine does not let his disability keep him from reaching his potential, as exemplified by climbing an old stump that used to house a tree swing he would use as a child with lifelong friend Will Guerry. In successfully ascending the tree stump independently for the first time on July 31, 2016, Dahreddine epitomizes perseverance against all odds.

Lola signs autographs for her family and friends during her Make-A-Wish event on November 13, 2016. Because of her love for cooking, The Make-A-Wish Foundation of Central New York gave Lola the opportunity to judge her own cooking competition, inspired by the Food Network TV show “Chopped.” In Lola’s World Class Food Festival, there were two rounds to the contest, where Lola selected her secret ingredients for the chefs to use.

Lola’s parents did not agree on a treatment plan for Lola, which revolved around the decision between quality of life and quantity of life. Agustin and Melissa gave Lola all the information from the doctors and let her decide for herself. The treatment Lola decided on includes radiation therapy as well as a drug trial regimen at St. Jude Children’s Research Hospital. This is a clinical trial to find out if a combination of two oral chemotherapy drugs, crizotinib and dasatinib, is safe for participants with DIPG after receiving radiation therapy. There is no cure and no guarantee the drugs will have an effect on Lola’s tumor. Lola decided to do the treatment not for herself, but for the future of DPIG. “I’d rather help find something for the other kids that will get DIPG then to not help at all,” she said. November 2, 2016.

Childhood cancer receives 4% of U.S. federal funding for cancer research and only 1% of this goes to DIPG. Lola is the first patient to qualify for Phase I of the clinical trial at St. Jude. The goal is to find if the child can withstand the side effects under the highest possible dose. December 16, 2016.

Lola has a hard time coming to terms with taking crizotinib in its liquid form, due to the bitter taste. On December 18, 2016, Lola threatens to give up and stop the treatment because she cannot handle the taste. Melissa discovered that dousing the medicine in chocolate syrup seemed to help Lola keep the medicine down. If she vomits within 30 minutes, she has to take a second dose.

Though cooking is one of Lola’s favorite pastimes, Lola feels too exhausted to even stand for a few minutes and decides to leave the kitchen to sit down. Lola’s medications make her very fatigued to the point that going from room to room wears her out. Melissa is considering getting Lola a wheelchair. February 3, 2017.

Lola has difficulty falling asleep at night due to the side effects from the steroids. Her inconsistent attendance in school has left her out of touch with classmates as she battles to keep DIPG from limiting her childhood. The uncertainty with how much time Lola has left to live leaves the family on edge. November 5, 2016.